
Please try another search
MELBOURNE (Reuters) - An Australian farmer has launched a legal case against Bayer (DE:BAYGN) AG's agricultural chemicals unit Monsanto (NYSE:MON) after being diagnosed with a type of leukaemia, the Australian Broadcasting Commission reported on Thursday.
New South Wales farmer Ross Wild was diagnosed with Hodgkin's Lymphoma last year after using the weedkiller Roundup on his farming property near the border of NSW and Victoria since 1976, ABC reported.
He claims that long-term exposure to Roundup's active ingredient, glyphosate, was to blame, ABC said.
Bayer did not have an immediate comment on the case.
He will be represented by managing partner Tony Carbone of Carbone Lawyers, according to the report. The firm did not did not immediately respond to an email requesting comment.
In June, Carbone Lawyers, acting for an Australian gardener, filed a lawsuit against Bayer for severe harm caused by a Roundup, the first such case in the country.
The lawsuit follows court rulings in the United States linking Roundup’s main ingredient, glyphosate, to cancer, which has already taken tens of billions of euros off Bayer’s market value.
For Bayer - inventor of Aspirin and maker of stroke prevention drug Xarelto and Yasmin birth control pills – lawsuits in the United States are the biggest headache with more than 13,400 plaintiffs bringing claims over the herbicide’s alleged cancer risk.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.